Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption

$1500 a month? Breakthrough obesity injection Wegovy (semaglutide) approved by the FDA — but high costs and limited insurance coverage likely to limit adoption

NPR | 
When a promising new drug to treat obesity was approved by the Food and Drug Administration for sale in the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists